Active — Not RecruitingEarly Phase 1

Effects of DL-endopeptidase Producing Probiotics on Human Intestinal NOD2 Ligands and Related Functions

China30 participantsStarted 2024-12-05

Plain-language summary

We have discovered a type of probiotic that can target activating intestinal NOD2, which is related to a series of human health issues.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Tend to participate the trial * Willing to provide written informed consent Exclusion Criteria: * Recent use of probiotics, antibiotics, laxatives, or gastrointestinal ulcer medications within the past month. * Gastrointestinal symptoms (e.g., constipation, abdominal pain, diarrhea, melena, hematochezia) in the past month. * Other conditions considered by researchers for exclusion

What they're measuring

safty

Timeframe: up to 2 weeks

NOD2 activation level

Timeframe: up to 2 weeks

Trial details

NCT IDNCT06716047

SponsorZhujiang Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-06-25

View on ClinicalTrials.gov More Microecological Therapy trials